Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4446_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать
17 Lateral Skull Base Pathologies
187
hemorrhage RBC breakdown foreign body reaction to cholesterol crystals [9]. Other features include the following:
• Clinical ndings: Usually asymptomatic, it may expand to compress CNs and brainstem.
• MRI ndings show nonenhancing lesion with T1 and T2 hyperintensity from both high uid and fat content (see Fig.17.8).
• Management: – Observe if not causing symptoms. – Surgical decompression for cranial neu-
ropathies, brainstem compression
– Transnasal approaches provide the wid-
est access for lesions with extension medial to the carotid.
– Lateral approaches: Infracochlear and
infralabyrinthine afford only narrow access but provides a route for aeration and drainage through connection with middle ear/mastoid.
17.3.2 Asymmetric Marrow
It is a variant of normal anatomy; it is found in around 5–10% of individuals as an asymptomatic imaging nding. It appears on MRI as nonen­hancing T1 hyperintense asymmetry. CT scan demonstrates normal, noneroded bone. No fol­low- up or treatment is required.
Fig. 17.7 MRI T1 with contrast shows dumbbell shape
meningioma of the right jugular foramen
Fig. 17.8 Axial CT and T1 MRI in two different patients
showing expansile lesion in the right and left petrous api­ces respectively displaying CT hypodensity and high
17.3.3 Eusion/Trapped Fluid
It occurs in a pneumatized petrous apex that trapped effusion. It is seen on imaging studies and in most cases is asymptomatic.
T1-WI signal intensity due to fatty contents representing cholesterol granuloma
188
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 17.9 Axial HRCT and T2WI MR showing evidence of right-sided otomastoiditis with opacication of pneuma-
tized right petrous apex and erosion of its posteromedial wall denoting petrous apicitis
Z. Altamimi et al.
CT shows petrous apex air cell opacication with present septations; MRI demonstrates a T1 hypointense, T2 hyperintense area with no enhancement.
Most cases are asymptomatic with no required intervention. For symptomatic patients, pro­longed antibiotics with a corticosteroid can be used, and rarely surgical drainage is required.
17.3.4 Cholesteatoma/Epidermoid
Cyst
Epithelial cyst within the petrous apex. Imaging studies demonstrate bone destruction on CT and restricted diffusion on DWI MRI.
Surgical excision is quite challenging in this area, if patient has a dead ear. A
translabyrinthine or transcochlear approach will give optimal access for the eradication of the cholesteatoma.
17.3.5 Petrous Apicitis
with abscess; otherwise does not enhance; T2 high signal (see Fig.
17.9).
Treatment is achieved by antibiotics if no improvement surgical drainage should occur by mastoidectomy and drainage.
17.3.6 Chordoma
It is a malignancy of the primitive notochord that usually arises from the midline with extension from clivus to petrous apex. It has a locally aggressive behavior. Skull base chordomas account for only 0.1–0.2% of all intracranial tumors [10]. CT shows a destructive lesion with calcication foci and enhances on T1 with con­trast, which may be difcult to differentiate from chondrosarcoma.
The optimal treatment involves radical sur­gery plus adjuvant radiotherapy. Chordoma car­ries a poor prognosis with a high rate of recurrence, even after extensive surgery and adju­vant radiotherapy [
10].
Petrous apicitis is a rare complication of otomas­toiditis especially in individuals with a pneuma-
17.3.7 Chondrosarcoma
tized petrous apex. There is a classic triad of sixth nerve palsy, deep facial pain, and ipsilateral otor­rhea, which is referred to as Gradenigo syndrome, although it may not be present in every patient [8].
CT scan demonstrates air cell coalescence; T1
intermediate signal may have an enhancing ring
It is a rare cartilaginous tumor. It arises from skull base synchondroses, most commonly from the petroclival region [10]. It presents as a destructive lesion that invades bone and extends into soft tissues and can manifest with headache
AL GRAWANY
17 Lateral Skull Base Pathologies
189
and diplopia. The lesion is located in the central or paramedian skull base. The diagnosis of chon­drosarcoma is radiological; CT shows irregular bone destruction, may have “popcorn” calcica­tions, and enhances on T1 with contrast.
Treatment is surgical resection; both radiation therapy and chemotherapy are of no benet as primary therapy, but radiotherapy (proton beam) may be of benet in cases of subtotal resection and recurrent tumor [11].
17.3.8 Metastasis
The petrous apex is the most common site of metastatic spread within the temporal bone [8]. Breast cancer is the most common primary meta­static cancer, followed by lung, prostate, kidney, and melanoma primary cancers.
17.4 Diuse Temporal Bone/
Other Skull Base Lesions
17.4.1 Fibrous Dysplasia
It is a focal condition where medullary bone is replaced by bro-osseous tissue. Usually mono­stotic (localized to one site), progressive external auditory canal occlusion with conductive hearing loss rarely causes sensorineural hearing loss. Diagnosis is usually made by CT scan, which shows “ground glass” expansive mass; treatment is mainly observation, may consider canaloplasty for conductive hearing loss or cholesteatoma for­mation behind canal stenosis, and radiotherapy should be avoided.
17.4.2 Eosinophilic Granuloma
It is the most common form of Langerhans cell histiocytosis, known as the localized form, it car­ries the best prognosis [12]. It typically affects mastoid, the external auditory canal (EAC), and petrous apex, and may involve entire temporal bone; it affects older children and young adults. It presents as painful postauricular swelling, or
with granulation and otorrhea of EAC.CT scan shows areas of bony destruction, and MRI T1 with contrast shows enhancement. Treatment is conservative, surgical excision, or low-dose radiotherapy for inaccessible or recurrent lesions.
17.4.3 Rhabdomyosarcoma
It is the most common temporal bone malignancy of children. It affects the middle ear and mastoid. It is divided into four histologic types: embryo­nal, botryoid, alveolar, and pleomorphic. The embryonal type is the most common. It presents with chronic otalgia and otorrhea that fails to respond to appropriate medical therapy. Treatment includes limited surgical intervention, external beam radiotherapy, and chemotherapy.
17.4.4 Endolymphatic Sac Tumor
It is a rare malignancy of the inner ear, originat­ing from the endolymphatic sac on the postero­medial wall of the temporal bone. It is slow growing, but locally destructive tumor with a low risk of distant metastases.
It is histologically shown as papillary adeno­mas. It has an association with Von-Hippel– Lindau (VHL) syndrome (seen in 10–30% of VHL patients); therefore, these patients require screening [10].
The diagnosis is mainly by imaging; CT scan shows a soft tissue mass on the posterior petrous face with a destruction of adjacent regions of the temporal bone with a characterizing expansile appearance. MRI shows retrolabyrinthine lesion with hyperintense T1, heterogeneous T2 signal, and T1 with contrast reveals heterogeneous enhancement (see Fig.17.10).
The treatment is best achieved with early and complete tumor resection. Different lateral skull base approaches can be used according to tumor localization, tumor size, and invasion. It is a highly vascularized tumor with a higher risk of bleeding. Radiotherapy can be utilized depend­ing on the disease stage [10].
190
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 17.10 Axial and coronal MRI T1 with contrast reveals heterogeneous enhancement of right ear endolymphatic sac
tumor
Z. Altamimi et al.
17.4.5 Osteopetrosis
It is a rare disorder of bone remodeling with a symmetrical increase in bone density because of defective function of the osteoclasts. It presents in two types, an autosomal dominant (AD) type and an autosomal recessive (AR) type. The AD, also known as Albers-Schonberg disease, is the more common type, affecting the head and man­dible including the temporal bone and ossicles but it spars the otic capsule. It presents with cra­nial neuropathies due to compression at neural foramina. The AR, also known as malignant infantile osteopetrosis, is more severe with higher morbidity and mortality.
The treatment focuses on symptomatic man­agement, and decompression interventions of the facial nerve and the cochlear nerve may be of benet. Bone marrow transplantation also has been described for malignant osteopetrosis.
Take-Home Messages
• Glomus tumors considered the most common benign tumor of the temporal bone and middle ear of adults. Glomus jugulare is the most common type involving the jugular fossa.
• Glomus tumors can present with differ­ent types of associated cranial nerve syndromes, including Vernet syndrome, Collet–Sicard syndrome, and Villaret syndrome.
Jugular foramen lesions surgical exci-
sion is quite challenging and might require advance approaches such as transmastoid-transcervical, and infra­temporal fossa approach.
• Cholesterol granuloma is the most com­mon pathologic lesion found in the petrous apex.
AL GRAWANY
17 Lateral Skull Base Pathologies
• Petrous apicitis can present with classic triad of sixth nerve palsy, deep facial pain, and ipsilateral otorrhea, which is referred to as Gradenigo syndrome.
• The petrous apex is the most common site of metastatic spread within the tem­poral bone, and most commonly metas­tasize from breast cancer.
• Fibrous dysplasia is characterized by “ground glass” on CT scan. Radiotherapy should be avoided as it carries a risk of malignant transformation.
References
1. Ramina R, Maniglia JJ, Fernandes YB, Paschoal JR, Pfeilsticker LN, Neto MC, Borges G.Jugular foramen tumors: diagnosis and treatment. Neurosurg Focus. 2004;17(2):E5.
2. Borba LA, Araújo JC, de Oliveira JG, Filho MG, Moro MS, Tirapelli LF, Colli BO. Surgical man­agement of glomus jugulare tumors: a proposal for approach selection based on tumor relationships with the facial nerve. J Neurosurg. 2010;112(1):88–98.
3. Fish JH, Klein-Weigel P, Biebl M, etal. Systematic screening and treatment evaluation of hereditary neck paragangliomas. Head Neck. 2007;29(9):864–73.
191
4. Drovdlic CM, Myers EN, Peters JA, etal. Proportion of heritable paraganglioma cases and assodated clini­cal characteristics. Laryngoscope. 2001;111:1822–7.
5. Fayad JN, Keles B, Brackmann DE.Jugular foramen tumors: clinical characteristics and treatment out­comes. Otol Neurotol. 2010;31:299–305.
6. Weissman JL, Hirsch BE. Imaging of tinnitus: a review. Radiology. 2000;216:342–9.
7. Willen SN, Einstein DB, Maciunas RJ, et al. Treatment of glomus jugulare tumors in patients with advanced age: planned limited surgical resection fol­lowed by staged gamma knife radiosurgery: a prelimi­nary report. Otol Neurotol. 2005;26:1229–34.
8. Isaacson B, Kutz JW, Roland PS. Lesions of the petrous apex: diagnosis and management. Otolaryngol Clin N Am. 2007;40(3):479–519.
9. Jadder RK, Cho M. A new theory to explain the genesis of petrous apex cholesterol granuloma. Otol Neurotol. 2003;24:96–106.
10. Zanoletti E, Mazzoni A, Martini A, et al. Surgery of the lateral skull base: a 50-year endeavour. Acta Otorhinolaryngol Ital. 2019;39(Suppl 1):S1–S146. https://doi.
org/10.14639/0392-100X-suppl.1-39-2019.
11. Lustig LR, Sciubba J, Holliday MJ.Chondrosarcoma of the skull base and temporal bone. J Laryngol Otol. 2007;121:725–35.
12. Bayazit Y, Sirikci A, Bayaram M, Kanlikama M, Demir A, Bakir K.Eosinophilic granuloma of the tem­poral bone. Auris Nasus Larynx. 2001;28(1):99–102.
The Facial Nerve
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
HassanHaidar andSuzanMohamed
18
18.1 Introduction
The facial nerve can be affected anywhere along its course. A comprehensive assessment con­sidering all differential diagnoses is critical to optimal management, as prompt and appropri­ate therapy leads to better outcomes. The chapter will cover the anatomy, pathology, investigation, and intervention. Information is organized to cover the most common pathology followed by least common and then rare conditions.
18.2 Facial Nerve Anatomy
The facial nerve runs from the brain stem to facial muscles, and it has seven segments: intracranial meatal segment meatal foramen laby­rinthine segment tympanic segment mastoid segment extratemporal segment [1].
In the parotid, the facial nerve divides into ve branches (extratemporal branches): tempo­ral, zygomatic, buccal, marginal mandibular, and cervical.
The Narrowest segment of nerve (0.68 mm) occurs at meatal foramen [2] and is thepresumed
H. Haidar (*) Hamad Medical Corporation, Doha, Qatar
S. Mohamed Otolaryngology Department, Hamad General Corporation, Doha, Qatar e-mail: SMohamed50@hamad.qa
site of nerve injury in Bell’s palsy and therefore is site of facial nerve decompression.
Dehiscence is the most common variation of facial nerve, and the most frequent dehiscent areas are: tympanic segment > geniculate (middle fossa) > mastoid (adjacent to retrofacial cells).
In the brainstem, three nuclei give rise to the facial nerve:
1. Facial motor (voluntary facial movement),
2. Superior salivatory (parasympathetic effer-
ents for tearing and salivation),
3. Nucleus of the solitary tract (sensory afferents
for taste).
The facial nerve trunk consists of approxi­mately 10,000 nerve bers, approximately 7000 of which are myelinated motor bers. The remaining 3000 bers are somatosensory and secretomotor, and are known as the Nervus Intermedius.
The facial nerve sheath consists of several layers. The endoneurium, closely adherent to the layer of Schwann cells of the axons, surrounds each nerve ber. The perineurium, which is the intermediate layer surrounding groups of fasci­cles, provides tensile strength to the nerve and is believed to represent the primary barrier to the spread of infection. The outermost layer of the nerve is the epineurium. This outer layer contains the vasa nervorum, which provides the blood supply to the nerve.
© Springer Nature Switzerland AG 2021 A. Al-Qahtani et al. (eds.), Textbook of Clinical Otolaryngology,
https://doi.org/10.1007/978-3-030-54088-3_18
AL GRAWANY
193
194
Sunderland Classification of Facial Nerve Injuries
° Class I: Neuropraxia; compression of axon, no axonal disruption ° Class II: Axonotmesis; disruption of axon; endoneurium, perineurium, and epineurium still intact ° Class III: Neurotmesis; disruption of endoneurium surrounding axon; perineurium and endoneurium still intact, risk for synkinesis ° Class IV: Neurotmesis; disruption of perineurium and endoneurium, epineurium still intact
H. Haidar and S. Mohamed
18.3 House–Brackmann Scale
The House–Brackmann Facial Nerve Grading System is widely used to characterize the degree of facial paralysis. In this scale, grade I is assigned to normal function, and grade VI represents com­plete paralysis. Intermediate grades vary accord­ing to function at rest and with effort (Fig.18.1).
18.4 Facial Nerve Injury andRegeneration
18.4.1 Facial Nerve Injury Classication (Fig.18.2)
1. Neuropraxia
(a) Axon and supporting tissues remain intact (b) No Wallerian degeneration (c) Complete recovery
2. Axonotmesis
(a) Loss of continuity of the axon (b) Wallerian degeneration occurs (c) Complete recovery, no synkinesis
3. Neurotmesis
(a) Injury involves endoneurium (b) Wallerian degeneration occurs (c) Increasing risk of synkinesis and incom-
plete recovery with increasing Sunderland class
In facial palsy, there can be a combina-
tion of injuries occurring at the same time.
Electrodiagnostic testing is useful to demonstrate the most prevalent degree of injury.
Electrodiagnostic testing can determine per­centage of bers stimulable (neuropraxia) versus non-stimulable (axonotmesis and neurotmesis).
Unfortunately, no current testing can distin­guish between axonotmesis from neurotmesis. More rapid degeneration indicates more severe injury and most likely neurotmesis.
Wallerian degeneration is a process that occurs before nerve regeneration and can be described as a cleaning or clearing process that essentially pre­pares the distal stump for reinnervation. Schwann cells proliferate and form endoneurial tubes with the remaining connective tissues that guide regen­eration of the axon to its nal destination.
Electrical stimulation can promote nerve regeneration [3].
When nerve bers are damaged, they may aberrantly regenerate. During regeneration, excessive collateral branching of the axons occurs, not only at the site of the lesion but also along the entire course of the nerve. These extra­axons may result in synkinesis. An example of abnormal neural regrowth is “crocodile tears,” or increased lacrimation associated with eating. It occurs when efferent bers normally targeted to travel with the chorda tympani nerve to the sub­mandibular and sublingual glands are misdirected through the greater supercial petrosal nerve to the lacrimal gland. This results in parasympa­thetic innervations of the lacrimal gland as well as the normal target, the salivary glands. As a result,
Fig. 18.1 House–
Brackmann classication of facial palsy
Fig. 18.2 Sunderland classication of facial nerve injuries
° I: Normal function ° II: Slight weakness but symmetric at rest, good forehead motion ° III: Obvious weakness but symmetric at rest, impaired forehead motion, able to close eye, may have synkinesis or contracture ° IV: Symmetric at rest, incomplete eye closure, no forehead motion ° V: Asymmetry at rest, barely perceptible movement ° VI: Asymmetry at rest, no movement
House–Brackmann Classification
18 The Facial Nerve
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
195
when eating, instead of getting the normal sali­vary response to increase the salivation, the neu­ronal signal causes tearing of the lacrimal gland.
These abnormal movements can be more dis­tressing than the facial palsy itself. Botulinum toxin injection and facial reanimation are among the proposed methods of treatment.
18.5 Facial Nerve Function Tests
It is used to assess integrity of nerve in cases of complete facial paralysis (for paresis not used because nerve is intact).
18.5.1 Electroneuronography (ENoG:
Evoked EMG)
It records facial muscle compound action poten­tials (CAP) in response to transcutaneous electri­cal stimulation (stimulating electrode placed at the region of stylomastoid foramen).
It provides an objective measure of action potential amplitudes from normal and paralyzed sides.
It should NOT be done until 2–3days after injury (wait for Wallerian degeneration to occur).
It predicts prognosis and determines the cri­teria for surgical intervention in traumatic/Bell’s palsy (>90% denervation). In Bell’s palsy: middle fossa decompression is suggested if >90% degen­eration compared to normal side within 2weeks.
18.5.2 Electromyography (EMG)
It determines the level of spontaneous muscle activity, and it is useful in predicting prognosis for acute or long-standing paralysis.
Fibrillation  Seen in denervated muscle ~2weeks after injury.
Silence  Muscle atrophy (long-standing denervation).
• Polyphasic potentials  seen with muscle
reinnervation ~6weeks after injury
• Normal voluntary action potentials indicate at
least partial nerve continuity.
18.5.3 Nerve Excitability Test (NET)
It compares the lowest current stimulation thresh­old required to cause minimal muscle contraction on each side of the face (difference >3.5mA con­sidered signicant); it requires subjective obser­vation by tester.
18.5.4 Maximum Stimulation Test (MST)
It compares muscle movement on each side of face in response to suprathreshold current stimu­lation, stimulation probe placed in the region of nerve branch to be tested; it requires subjective grading by tester.
18.6 Unilateral Facial Nerve Weakness (Fig.
18.3)
18.6.1 Congenital Facial Palsy
Congenital causes include obstetric, develop­mental facial paralysis, Möbius syndrome, and idiopathic mandibular division palsy.
Obstetric injury, often with forceps delivery,
is the commonest cause of congenital cause; most recover within a month.
Idiopathic marginal mandibular nerve palsy
(congenital unilateral lower lip palsy/CULLP) causes unilateral weakness of depressor anguli oris and is associated with other major con­genital anomalies in 10% of children, most commonly the cardiovascular system. It affects about one in 160 live births.
Möbius syndrome is a rare condition of
unknown origin. Children usually present at an early age with facial and ocular symptoms which include incomplete eye closure, mask­like face, inability to follow gaze, drooling, and difculty sucking. The facial nerve is always involved, the abducens nerve is involved in 75–100% of cases, and the hypo­glossal nerve is commonly implicated. Other cranial nerves may be involved. The condition is often bilateral.
AL GRAWANY
196
weakness
H. Haidar and S. Mohamed
Unilateral facial weakness
Congenital Infectious
Mobius syndrome:
CN VII/VI palasies,
club foot, mental
retardation
Congenital lower lip
palsy:
Hypoplasia of
depressor anguli
oris muscle, cardiac
defects
Fig. 18.3 Causes of unilateral facial palsy
Bell’s palsy
Herpes zoster
oticus/Ramsay
Hunt syndrome
HIV
Lyme disease:
10 % develop
ipsilateral or
bilateral facial
Limb abnormalities may be present in up to 25% of cases.
Goldenhar’s syndrome comprises hemifacial microsomia, epibulbar dermoid cysts, and ver­tebral anomalies, and may have facial nerve weakness.
18.6.2 Bell’s Palsy
It is the most common cause of unilateral facial weakness/paralysis, and idiopathic but viral eti­ology is suspected.
Risk factors: Diabetes, pregnancy, and prior
history (10% recur).
18.6.2.1 Clinical
– Acute unilateral weakness or paralysis devel-
ops within 48h.
– May have viral prodrome, hyperacusis,
decreased tearing, numbness/pain of ear/face/ neck, and taste changes
Traumatic
TB fracture
latrogenic
Chronic
Cholesteatoma
Neoplastic:
Schwannom, glomus,
parotid tumor
Melkerson−Rosenthal
syndrome:
begins in childhood
recurrent facial edema
recurrent facial weakness
recurrent fissured tomgue;
treat with steroids
ENoG can be considered for patients with
complete paralysis, and it is used to determine candidacy for surgical intervention.
18.6.2.2 Treatment
High-dose steroids (prednisone 1 mg/kg)
increase the rate of recovery.
– No evidence of improvement with addition of
antivirals to steroids [4]
– Eye care if difculty with eye closure to pre-
vent exposure keratitis (saline drops, lacrilube ointment, and eye bubble)
Surgery: Middle fossa decompression for
patients under 65 with >90% neuronal degen­eration within 2weeks of onset
18.6.2.3 Prognosis
More than 90% of patients will completely recover [5].
It shows poor prognosis with advanced age
and complete paralysis.
18 The Facial Nerve
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
197
18.6.3 Traumatic Facial Palsy
Trauma is the second commonest cause and may be due to temporal bone fracture, penetrating wounds, or obstetric injury.
18.6.3.1 Blunt Trauma
• Longitudinal versus transverse (see chapter TB fracture)
• Facial paralysis is more likely with transverse fractures
• Most commonly injured at perigeniculate region
• Management analogous to Bell’s palsy
– Medical: High-dose steroids (prednisone
1mg/kg)
– Surgical: Consider decompression for
patients with immediate complete paralysis and >90% neuronal degeneration on ENoG within 2weeks of onset. If no hearing, per­form translabyrinthine exploration; if hear­ing is still present, combined middle fossa/ transmastoid exploration is performed.
18.6.3.2 Penetrating Trauma
– Gunshots, knives, … – High risk of nerve transection – Nerve injury to facial nerve branches medial
to a line drawn vertically through the lateral canthus of the eye may retain facial movement because of the degree of arborization
– Injury to the frontal and marginal mandibular
nerves manifesting with weakness should always be repaired as the likelihood of sponta­neous recovery is poor. Nerve repair should ideally be done within 72h to permit identi­cation of the distal ends of the severed nerves by electrical stimulation; beyond 72 h neu­rotransmitter stores may become depleted.
18.6.4 Herpes Zoster Oticus/Ramsay Hunt Syndrome
Herpes zoster oticus: Reactivation of herpes zoster virus (normally dormant in geniculate ganglion) with cutaneous lesions in distribution of nervus intermedius (CN VII).
Since the vestibulocochlear nerve is in prox­imity to the geniculate ganglion, it may also be affected, and patients may also suffer from tinni-
tus, hearing loss, and vertigo. Involvement of the
trigeminal nerve can cause numbness of the face.
Ramsay Hunt syndrome: Herpes zoster oti­cus + facial paralysis, 18% of adult facial palsies.
18.6.4.1 Clinical
– Shingles in external auditory canal, pinna,
anterior 2/3s of tongue, and soft palate;
– Facial paresis/paralysis with Ramsey Hunt
syndrome,
– May have associated hearing loss (50% of
patients, due to involvement of CN VIII), also
tinnitus and vertigo/disequilibrium
18.6.4.2 Diagnosis
– Audiogram may show sensorineural hearing
loss;
– MRI to evaluate the course of facial nerve
18.6.4.3 Treatment
– Treatment with prednisone and acyclovir
800mg ve times a day started within the rst
3 days of facial paralysis may increase the
probability of complete recovery [6]
– Consider anticonvulsants (carbamazepine,
gabapentin, lyrica) for postherpetic neuralgia
Prognosis: Increased risk of residual facial weakness compared to Bell’s palsy.
Surgical Pearl
At birth, the facial nerve exits in the stylo­mastoid foramen on the lateral aspect of the skull, just inferior to the tympanic mem­brane and external ear canal. This makes the facial nerve vulnerable to traumatic injury during difcult delivery.
18.6.5 Acute Otitis Media
andMastoiditis
It is typically seen in children who appear toxic with otoscopic ndings of middle ear empyema.
The palsy is often progressive in over a 2–3­day interval.
AL GRAWANY